Prevention for pediatric low cardiac output syndrome: Results from the European survey EuLoCOS-Paed

Paediatric Anaesthesia

Volumn 21, Issue 12, 2011, Pages 1176-1184

  Vogt, Winnie ^a   Läer, Stephanie ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

cardiopulmonary bypass; congenital heart defect; Europe; low cardiac output syndrome; preventive therapy; questionnaire

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; ENOXIMONE; GLYCERYL TRINITRATE; INOTROPIC AGENT; LEVOSIMENDAN; METHYLPREDNISOLONE; MILRINONE; PHENYLEPHRINE;

EUROPE; FORWARD HEART FAILURE; HEALTH SURVEY; HOSPITAL; HUMAN; MAINTENANCE THERAPY; MONOTHERAPY; OPEN HEART SURGERY; PERIOPERATIVE PERIOD; PRESCRIPTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW;

CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CHILD, PRESCHOOL; DOBUTAMINE; DOPAMINE; DRUG THERAPY, COMBINATION; EPINEPHRINE; EUROPE; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; HYDRAZONES; INFANT; MILRINONE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PYRIDAZINES; QUESTIONNAIRES;

EID: 80055005387     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03683.x     Document Type: Review

References (27)

1. Moons P, Sluysmans T, De Wolf D, et al. Congenital heart disease in 111 225 births in Belgium: birth prevalence, treatment and survival in the 21st century. Acta Paediatr 2009; 98: 472-477.
2. Massé L, Antonacci M,. Low cardiac output syndrome: identification and management. Crit Care Nurs Clin North Am 2005; 17: 375-383. (Pubitemid 41773429)
3. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002. (Pubitemid 36258723)
4. Ma M, Gauvreau K, Allan CK, et al. Causes of death after congenital heart surgery. Ann Thorac Surg 2007; 83: 1438-1445. (Pubitemid 46440755)
5. Bishara T, Seto WT, Trope A, et al. Use of milrinone in critically ill children. CJHP 2010; 63: 420-428.
6. Vogt W, Läer S,. Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe. Intensive Care Med 2011; 37: 1390-1391.
7. Leone M, Vallet B, Teboul J, et al. Survey of the use of catecholamines by French physicians. Intensive Care Med 2004; 30: 984-988. (Pubitemid 38639497)
8. Kastrup M, Markewitz A, Spies C, et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand 2007; 51: 347-358.
9. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
10. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37: 666-688.
11. Carl M, Alms A, Braun J, et al. Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine. Thorac Cardiovasc Surg 2007; 55: 130-148. (Pubitemid 47234737)
12. Dillman DA,. Mail and Internet Surveys: The Tailored Design Method, 2nd edn. Hoboken, NJ: John Wiley & Sons Inc, 2007.
13. Carcillo JA, Piva JP, Thomas NJ, et al. Shock and shock syndromes. In:, Slonim A, Pollack M, Bell MJ, Berger J, Carcillo JA, eds. Pediatric Critical Care Medicine. Philadelphia, PA: Lippincott Williams and Wilkins, 2006: 438-471.
14. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011; 2011. Available at:. Accessed 18 April, 2011.
15. Altman DG, Machin D, Bryant TN, et al. Statistics with Confidence, 2nd edn. Bristol: BMJ Books, 2000.
16. Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%- a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113-118. (Pubitemid 28204263)
17. Carmona F, Manso PH, Vicente WVA, et al. Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I. Cytokine 2008; 42: 317-324.
18. Allen M, Sundararajan S, Pathan N, et al. Anti-inflammatory modalities: their current use in pediatric cardiac surgery in the United Kingdom and Ireland. Pediatr Crit Care Med 2009; 10: 341-345.
19. Alphonso N, Anagnostopoulos PV, Scarpace S, et al. Perioperative antibiotic prophylaxis in paediatric cardiac surgery. Cardiol Young 2007; 17: 12-25. (Pubitemid 46322005)
20. Wernovsky G, Ghanayem N, Ohye RG, et al. Hypoplastic left heart syndrome: consensus and controversies in 2007. Cardiol Young 2007; 17 (Suppl 2): 75-86. (Pubitemid 350237747)
21. Gombotz H, Lechner E, Hofer A, et al. Levosimendan versus milrinone after biventricular corrective cardiac surgery. Presented at the 2010 Annual Meeting of the American Society of Anesthesiologists in San Diego, CA: October 16-20, 2010. Available at:. Accessed 10 May, 2011.
22. Bailey JM, Hoffman TM, Wessel DL, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 2004; 31: 43-59. (Pubitemid 38870189)
23. Nizami SQ, Khan IA, Bhutta ZA,. Differences in self-reported and observed prescribing practice of general practitioners and paediatricians for acute watery diarrhoea in children of Karachi, Pakistan. J Diarrhoeal Dis Res 1995; 13: 29-32.
24. Adams AS, Soumerai SB, Lomas J, et al. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999; 11: 187-192. (Pubitemid 29302446)
25. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century, 1st edn. Washington, DC: National Academies Press, 2001.
26. European Medicines Agency. Revised priority list for studies into off-patent paediatric medicinal products for the Fifth Call 2011 of the 7th Framework Programme of the European Commission, Rev. 2010 (Doc. Ref.: EMA/253396/2010). Accessed 28 July, 2010.
27. Roth SJ, Adatia I, Pearson GD, et al. Summary proceedings from the cardiology group on postoperative cardiac dysfunction. Pediatrics 2006; 2 (3 Pt 2): S40-S46. (Pubitemid 46063171)